7
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60047 | V-0219 | Glucagon Receptor | GPCR/G Protein |
V-0219 是 GLP-1 的正变构调节剂,可用于肥胖相关糖尿病的研究。 | |||
T60047L |
V-0219 hydrochloride
V-0219 hydrochloride(878453-71-5 Free base) |
Glucagon Receptor | GPCR/G Protein |
V-0219 hydrochloride 是一种具有口服活性的 glucagon-like peptide-1 receptor (GLP-1R) 正向别构调节剂 (PAM)。V-0219 能被用于肥胖相关糖尿病的研究。 | |||
T3283 |
Cetilistat
新利司他,ATL-962 |
Lipid | Metabolism |
Cetilistat (ATL-962) 是胰腺脂肪酶 (pancreatic lipase) 抑制剂,能够抑制大鼠脂肪酶(IC50:54.8 nM)和人胰脂肪酶(IC50:5.95 nM)的活性,可用作有效的抗肥胖药。 | |||
T39488 | Relzomostat | ||
Relzomostat is a MetAP2 inhibitor, specifically targeting methionine aminopeptidase 2. It holds potential in research concerning obesity, type 2 diabetes, and other conditions associated with obesity. | |||
T40950 | A3334 | ||
A3051, is a robust and orally active inhibitor of CXXC5-DVL with an IC 50 of 63.06 nM. Its applications include research into phenotypes associated with obesity, diabetes, and NASH that are induced by high fat diet (HFD) and methionine-choline deficient diet (MCD). | |||
T81628 |
OB3
|
||
OB3, 相比于Leptin,在降低小鼠模型的肥胖和糖尿病方面显示出更高效。此化合物能够降低肝癌细胞内瘦素相关的炎症及其增殖作用。 | |||
T74672 |
Sirtuin modulator 5
|
||
Sirtuinmodulator 5 是一种sirtuin 调节剂。Sirtuinmodulator 5 可以激活SIRTl,DC50值 <50 μM。Sirtuinmodulator 5 可用于增加细胞的寿命并用于研究多种疾病,包括例如与衰老或压力、糖尿病、肥胖症、神经退行性疾病、心血管疾病、凝血障碍、 炎症、癌症和/或潮红以及将受益于线粒体活性增加的疾病或病症。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4723 |
D-Tagatose
塔格糖,D-(-)-Tagatose,D-塔格糖,d-tagatos |
Others; Endogenous Metabolite | Metabolism; Others |
D-Tagatose (D-(-)-Tagatose) 是自然界中发现的一种罕见的单糖,具有益生元特性。它是研究II 型糖尿病的潜在抗糖尿病药物,也是帮助提升结肠有益细菌、预防结肠癌和抑制胆固醇的益生元。它是蔗糖的替代品,也是口香糖、果汁和饮料等食品中的低热量甜味剂。 |